GW&K Investment Management’s Moderna MRNA Stock Holding History

GW&K Investment Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18K	Buy	359 +22	+7%	+$1.03K	﹤0.01%	795
2025 Q4	$10K	Sell	337 -45	-12%	-$1.22K	﹤0.01%	864
2025 Q3	$10K	Buy	382 +20	+6%	+$558	﹤0.01%	860
2025 Q2	$10K	Buy	362 +168	+87%	+$4.42K	﹤0.01%	853
2025 Q1	$5K	Buy	194 +34	+21%	+$1.21K	﹤0.01%	912
2024 Q4	$7K	Buy	160 +10	+7%	+$478	﹤0.01%	846
2024 Q3	$10K	Sell	150 -14	-9%	-$1.28K	﹤0.01%	784
2024 Q2	$19K	Buy	164 +39	+31%	+$4.93K	﹤0.01%	580
2024 Q1	$13K	Buy	125 +9	+8%	+$907	﹤0.01%	634
2023 Q4	$12K	Sell	116 -1	-0.9%	-$84	﹤0.01%	629
2023 Q3	$12K	Buy	117 +5	+4%	+$558	﹤0.01%	576
2023 Q2	$14K	Buy	112 +110	+5,500%	+$14.7K	﹤0.01%	526
2023 Q1	$0	Buy	+2	New	+$330	﹤0.01%	556
2022 Q3	–	Sell	-42	Closed	-$6K	–	675
2022 Q2	$6K	Buy	42 +20	+91%	+$2.86K	﹤0.01%	562
2022 Q1	$4K	Buy	+22	New	+$3.7K	﹤0.01%	586

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return